Beginning Cash: The amount of cash reported by the company on its previous statement.
ANI Pharmaceuticals, Inc. (ANIP) had Beginning Cash of $144.89M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$247.06M |
|
$27.49M |
|
$100.27M |
|
$146.79M |
|
$212.29M |
|
$34.77M |
|
$-3.29M |
|
$31.48M |
|
$31.48M |
|
$27.49M |
|
$27.49M |
|
$27.49M |
|
$27.49M |
|
$34.77M |
|
$57.38M |
|
20.05M |
|
21.23M |
|
$1.24 |
|
$1.14 |
|
| Balance Sheet Financials | |
$753.12M |
|
$62.48M |
|
$687.26M |
|
$1.44B |
|
$278.11M |
|
$599.77M |
|
$621.54M |
|
$899.65M |
|
$540.72M |
|
$-1.28M |
|
$540.72M |
|
22.50M |
|
| Cash Flow Statement Financials | |
$185.22M |
|
$-34.32M |
|
$-9.94M |
|
|
Beginning Cash |
$144.89M |
$285.62M |
|
$140.73M |
|
$37.93M |
|
-- |
|
$-1.16M |
|
| Fundamental Metrics & Ratios | |
2.71 |
|
-- |
|
-- |
|
0.53 |
|
1.14 |
|
59.42% |
|
14.07% |
|
14.07% |
|
-- |
|
12.74% |
|
11.13% |
|
$171.39M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.70 |
|
0.88 |
|
102.39 |
|
5.08% |
|
-2144.23% |
|
1.91% |
|
2.41% |
|
$24.03 |
|
$8.07 |
|
$8.73 |
|